News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Tarlatamab and Lurbinectedin-Atezolizumab Combination Therapy Trials Meet Survival Endpoints: Alfredo Addeo in ESMO Daily Reporter
ESMO/X
Jun 14, 2025, 13:43

Tarlatamab and Lurbinectedin-Atezolizumab Combination Therapy Trials Meet Survival Endpoints: Alfredo Addeo in ESMO Daily Reporter

The European Society for Medical Oncology (ESMO) shared a post on X:

“Two studies investigating efficacy of bispecific T-cell engager tarlatamab and lurbinectedin – atezolizumab combination met their primary endpoints of survival.
Read the opinion by Alfredo Addeo in the ESMO Daily Reporter․“

More posts featuring ESMO Daily Reporter on OncoDaily.

Alfredo Addeo atezolizumab cancer ESMO ESMO Daily Reporter European Society for Medical Oncology Lung cancer Lurbinectedin OncoDaily Oncology SCLC
Special Coverage
Insight
Jun 14, 2025, 13:44
Nicholas DeVito Was Honored With Junior Faculty Teaching Award
Blog
Jun 14, 2025, 13:43
Tarlatamab and Lurbinectedin-Atezolizumab Combination Therapy Trials Meet Survival Endpoints: Alfredo Addeo in ESMO Daily Reporter
Science
Jun 14, 2025, 13:36
Emmanuel Mesny: Proud to Share Our Review On The Radiosensitivity of Brain Substructures After Cranial Radiotherapy
Blog
Jun 14, 2025, 13:31
Alba Fiorentino Shared Clinical Case of Glioblastoma Multiforme Treatment and Follow-Up MRI Results
Science
Jun 14, 2025, 13:18
CCR Researchers Snipped Over 12,000 Exons Out of the Genomes of Lab-grown Human Cells - NCI Center for Cancer Research
Blog
Jun 14, 2025, 13:10
Elisabete Weiderpass Thanks His Excellency President Luiz Inácio Lula da Silva for Supporting Cancer Research and Prevention - IARC
Oncolibrary
Jun 14, 2025, 13:07
Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?
Insight
Jun 14, 2025, 12:47
Amol Akhade shared an article: FDA Approves Perioperative Pembrolizumab Plus Radiation in HNSCC
Insight
Jun 14, 2025, 12:21
Register Now for SIOG NAHS Webinar on Pancreatic Cancer Care for Older Adults on June 26
Blog
Jun 14, 2025, 12:09
Naveen Pemmaraju and Fadi Haddad In New Episode of Cancerwise Podcast on The Future of Leukemia Treatment
Blog
Jun 14, 2025, 11:59
Jeff Molter: SurvivorNet Highlights What ASCO Findings on Exercise Mean for Cancer Patients
Insight
Jun 14, 2025, 11:55
SHRO Launched Translational Gynecology Program to Address $1 Trillion Global Women’s Health Gaps